332 related articles for article (PubMed ID: 8171003)
21. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
22. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
23. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
24. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
25. Regulation of expression of human immunodeficiency virus.
Pavlakis GN; Felber BK
New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
[TBL] [Abstract][Full Text] [Related]
26. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
27. RNA-sequence-mediated gene regulation in HIV-1.
Cullen BR
Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
[TBL] [Abstract][Full Text] [Related]
28. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
Graham GJ; Maio JJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
[TBL] [Abstract][Full Text] [Related]
29. The Molecular Basis for Human Immunodeficiency Virus Latency.
Mbonye U; Karn J
Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
[TBL] [Abstract][Full Text] [Related]
30. Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.
Michael NL; Vahey MT; d'Arcy L; Ehrenberg PK; Mosca JD; Rappaport J; Redfield RR
J Virol; 1994 Feb; 68(2):979-87. PubMed ID: 8289399
[TBL] [Abstract][Full Text] [Related]
31. Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionally cytotoxic adenovirus vector.
Venkatesh LK; Arens MQ; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8746-50. PubMed ID: 2247444
[TBL] [Abstract][Full Text] [Related]
32. Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.
Wu BY; Woffendin C; Duckett CS; Ohno T; Nabel GJ
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1480-4. PubMed ID: 7878004
[TBL] [Abstract][Full Text] [Related]
33. Rev of human immunodeficiency virus and Rex of the human T-cell leukemia virus type I can counteract an mRNA downregulatory element of the transferrin receptor mRNA.
Zolotukhin AS; Harford JB; Felber BK
Nucleic Acids Res; 1994 Nov; 22(22):4725-32. PubMed ID: 7984424
[TBL] [Abstract][Full Text] [Related]
34. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
35. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
36. Regulatory genes of human immunodeficiency viruses.
Wong-Staal F; Haseltine WA
Mol Genet Med; 1992; 2():189-219. PubMed ID: 1458225
[No Abstract] [Full Text] [Related]
37. [RNA ligands for HIV proteins].
Iwai S
Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
[No Abstract] [Full Text] [Related]
38. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
Unwalla H; Banerjea AC
Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
[TBL] [Abstract][Full Text] [Related]
39. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
[TBL] [Abstract][Full Text] [Related]
40. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.
Toohey MG; Jones KA
Genes Dev; 1989 Mar; 3(3):265-82. PubMed ID: 2542124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
